LU
LUCD
Lucid Diagnostics Inc.
$0.9610
-1.74%
$195.1M
No data for this timeframe.
Vol
Market Cap$195.1M
Cap SizeMicro Cap
Analyst ConsensusStrong Buy (91%)
Inst. Holders39 funds
Inst. Value$20.0M
Inst. Activity8 buys / 2 sells
Insider Activity1B / 0S
Insider Net $$245.3K
SEC Reports3
Exchange Nasdaq·Sector Surgical & Medical Instruments & Apparatus·Inc. DE·CIK 0001799011·Prev Close $0.9780
Recent Activity
Jun 9, 2026
short_volume
Short Volume: LUCD — 59.8% short (0.3M / 0.5M)
Short: 321,716 | Exempt: 222 | TRF Vol: 538,080 | Short Ratio: 59.8% | Off-exchange volume (dark poo
May 20, 2026
Insider
Matheis Dennis bought 245,000 shares
Director @ $1.00 ($245.3K)
May 14, 2026
SEC
Lucid Diagnostics reported Q1 2026 revenue of $1.3M (up 52% YoY from $0.8M) and a GAAP net loss of $0.17/share, which is
8-K — Impact 5/10
Apr 24, 2026
SEC
Lucid Diagnostics Inc. (LUCD) closed an underwritten public offering of 18 million shares at $1.00 per share, raising $1
8-K — Impact 5/10
Apr 23, 2026
SEC
Lucid Diagnostics is conducting an underwritten public offering of 18 million shares of common stock at a public offerin
8-K — Impact 5/10
Feb 20, 2026
Insider
Matheis Dennis was granted 123,000 shares
Director
Feb 20, 2026
Insider
White Debra was granted 123,000 shares
Director
Inst.
Russell Investments Group, Ltd. — DOUBLED
1,583,608 shares ($1.8M)
Price Targets
$3.95
+311.2% upside
Strong Buy
Current $0.9607
Low $2.00
Median $3.00
High $9.25
5 analysts
$2.00
$9.25
Analyst Ratings
3Strong Buy
7Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jun 8, 2026 | Ascendiant Capital | MAINTAIN | Buy → Buy |
| May 15, 2026 | Maxim Group | MAINTAIN | Buy → Buy |
| May 15, 2026 | BTIG | REITERATE | Buy → Buy |
| Apr 9, 2026 | Ascendiant Capital | MAINTAIN | Buy → Buy |
| Mar 30, 2026 | BTIG | REITERATE | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.06 ▲ +8.3% | $-0.07 — $-0.04 | 45% YoY | 4 |
| Next Q | $-0.05 ▲ +7.4% | $-0.06 — $-0.04 | 48% YoY | 4 |
| Current FY | $-0.24 ▼ -2.9% | $-0.27 — $-0.20 | 45% YoY | 3 |
| Next FY | $-0.17 ▲ +5.6% | $-0.19 — $-0.15 | 28% YoY | 4 |
Latest Reports
BEARISH
8-K
5/10
Lucid Diagnostics reported Q1 2026 revenue of $1.3M (up 52% YoY from $0.8M) and a GAAP net loss of $0.17/share, which is
May 14, 2026
NEUTRAL
8-K
5/10
Lucid Diagnostics Inc. (LUCD) closed an underwritten public offering of 18 million shares at $1.00 per share, raising $1
Apr 24, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BlackRock, Inc. | $5.3M | — |
| VANGUARD CAPITAL MANAGEMENT LLC | $4.8M | — |
| Russell Investments Group, Ltd. | $1.8M | DOUBLED |
| STATE STREET CORP | $1.8M | ADD |
| WELLS FARGO & COMPANY/MN | $1.5M | ADD |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 20, 2026 | Matheis Dennis | BUY | $245.3K |
| Feb 20, 2026 | Matheis Dennis | A | $0.00 |
| Feb 20, 2026 | White Debra | A | $0.00 |
| Feb 20, 2026 | Sparks Ronald | A | $0.00 |
| Feb 20, 2026 | Aklog Lishan | A | $0.00 |
39 institutional holders with $20.0M total value (17,456,025 shares) as of 2026-Q1. Top holders: BlackRock,, VANGUARD, Russell. Net buying activity: 8 institutions added/increased vs 2 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 4,638,243 | $5.3M | 26.7% | — |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 4,154,770 | $4.8M | 23.9% | — |
| 3 | Russell Investments Group, Ltd. | 1,583,608 | $1.8M | 9.1% | DOUBLED +15537.5% |
| 4 | STATE STREET CORP | 1,554,581 | $1.8M | 8.9% | ADD +32.9% |
| 5 | WELLS FARGO & COMPANY/MN | 1,274,390 | $1.5M | 7.3% | ADD +28.7% |
| 6 | VANGUARD FIDUCIARY TRUST CO | 623,557 | $717.1K | 3.6% | — |
| 7 | VANGUARD PORTFOLIO MANAGEMENT LLC | 528,769 | $608.1K | 3.0% | — |
| 8 | RAYMOND JAMES FINANCIAL INC | 524,936 | $603.7K | 3.0% | — |
| 9 | RENAISSANCE TECHNOLOGIES LLC | 499,661 | $574.6K | 2.9% | TRIM -39.5% |
| 10 | Lido Advisors, LLC | 383,082 | $440.5K | 2.2% | DOUBLED +173.6% |
| 11 | BANK OF MONTREAL /CAN/ | 285,236 | $328.0K | 1.6% | DOUBLED +1902.2% |
| 12 | GOLDMAN SACHS GROUP INC | 242,658 | $279.1K | 1.4% | — |
| 13 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 197,424 | $227.0K | 1.1% | ADD +28.6% |
| 14 | FMR LLC | 120,569 | $138.7K | 0.7% | DOUBLED +289.5% |
| 15 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 103,174 | $118.7K | 0.6% | — |
| 16 | Nuveen, LLC | 90,234 | $103.8K | 0.5% | TRIM -62.9% |
| 17 | BANK OF AMERICA CORP /DE/ | 88,527 | $101.8K | 0.5% | ADD +25.9% |
| 18 | DEUTSCHE BANK AG\ | 80,355 | $92.4K | 0.5% | — |
| 19 | Centiva Capital, LP | 69,063 | $79.4K | 0.4% | — |
| 20 | RHUMBLINE ADVISERS | 48,630 | $55.9K | 0.3% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| Russell Investments Group, Ltd. | DOUBLED | 10,127 | 1,583,608 | +15537.5% | $1.8M | 2026-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 826,527 | 499,661 | -39.5% | $574.6K | 2026-Q1 |
| BANK OF MONTREAL /CAN/ | DOUBLED | 14,246 | 285,236 | +1902.2% | $328.0K | 2026-Q1 |
| FMR LLC | DOUBLED | 30,958 | 120,569 | +289.5% | $138.7K | 2026-Q1 |
| BANK OF AMERICA CORP /DE/ | ADD | 70,315 | 88,527 | +25.9% | $101.8K | 2026-Q1 |
| MORGAN STANLEY | TRIM | 102,598 | 46,037 | -55.1% | $52.9K | 2026-Q1 |
| Mariner, LLC | ADD | 13,860 | 21,153 | +52.6% | $24.3K | 2026-Q1 |
| CWM, LLC | DOUBLED | 3,240 | 16,940 | +422.8% | $19.5K | 2026-Q1 |
| Allworth Financial LP | DOUBLED | 71 | 313 | +340.8% | $360.00 | 2026-Q1 |
| PRICE T ROWE ASSOCIATES INC /MD/ | DOUBLED | 35,136 | 74,377 | +111.7% | $86.00 | 2026-Q1 |
| STATE STREET CORP | ADD | 1,017,787 | 1,352,955 | +32.9% | $1.5M | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 714,313 | 919,479 | +28.7% | $1.0M | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | 293,633 | 826,527 | +181.5% | $900.9K | 2025-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | ADD | 174,868 | 224,921 | +28.6% | $245.2K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | ADD | 40,663 | 70,315 | +72.9% | $76.6K | 2025-Q4 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | ADD | 31,863 | 41,860 | +31.4% | $45.6K | 2025-Q4 |
| FMR LLC | DOUBLED | 303 | 30,958 | +10117.2% | $33.7K | 2025-Q4 |
| Russell Investments Group, Ltd. | ADD | 7,927 | 10,127 | +27.8% | $11.0K | 2025-Q4 |
| Allworth Financial LP | TRIM | 197 | 71 | -64.0% | $78.00 | 2025-Q4 |
| Alyeska Investment Group, L.P. | ADD | 738,277 | 1,383,116 | +87.3% | $1.4M | 2025-Q3 |
| STATE STREET CORP | ADD | 623,068 | 1,017,787 | +63.4% | $1.0M | 2025-Q3 |
| WELLS FARGO & COMPANY/MN | DOUBLED | 226,860 | 714,313 | +214.9% | $721.5K | 2025-Q3 |
| UBS Group AG | DOUBLED | 66,785 | 145,244 | +117.5% | $146.7K | 2025-Q3 |
| MORGAN STANLEY | NEAR_EXIT | 466,630 | 97,699 | -79.1% | $98.7K | 2025-Q3 |
| Nuveen, LLC | TRIM | 243,274 | 90,234 | -62.9% | $91.1K | 2025-Q3 |
11 unique insiders with 12 transactions. Net insider value: $245.3K ($245.3K bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 20, 2026 | Matheis Dennis | Director | BUY | 245,000 | $1.00 | $245.3K |
| Feb 20, 2026 | Matheis Dennis | Director | AWARD | 123,000 | — | — |
| Feb 20, 2026 | White Debra | Director | AWARD | 123,000 | — | — |
| Feb 20, 2026 | Sparks Ronald M | Director | AWARD | 123,000 | — | — |
| Feb 20, 2026 | Aklog Lishan | Chief Executive Officer | AWARD | 2,170,000 | — | — |
| Feb 20, 2026 | MCGRATH DENNIS M | Chief Financial Officer | AWARD | 470,000 | — | — |
| Feb 20, 2026 | O'Neil Shaun | President and COO | AWARD | 620,000 | — | — |
| Feb 20, 2026 | Cox James L | Director | AWARD | 123,000 | — | — |
| Feb 20, 2026 | SOKOLOV JACQUE J | Director | AWARD | 123,000 | — | — |
| Feb 20, 2026 | PALUMBO JOHN R | Director | AWARD | 123,000 | — | — |
| Feb 20, 2026 | Lapidus Stanley | Director | AWARD | 123,000 | — | — |
| Feb 20, 2026 | Gordon Michael Adam | General Counsel and Secretary | AWARD | 300,000 | — | — |
3 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 2 neutral. Avg impact: 5.0/10.
BEARISH
8-K
5/10
Lucid Diagnostics reported Q1 2026 revenue of $1.3M (up 52% YoY from $0.8M) and a GAAP net loss of $
May 14, 2026
NEUTRAL
8-K
5/10
Lucid Diagnostics Inc. (LUCD) closed an underwritten public offering of 18 million shares at $1.00 p
Apr 24, 2026
NEUTRAL
8-K
5/10
Lucid Diagnostics is conducting an underwritten public offering of 18 million shares of common stock
Apr 23, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (91% buy). Based on 11 analysts: 3 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$3.95 mean target
+311.2% upside
Strong Buy (1.40)
$2.00 Low
$9.25 High
| Metric | Value |
|---|---|
| Current Price | $0.9607 |
| Target Low | $2.00 |
| Target Mean | $3.95 |
| Target Median | $3.00 |
| Target High | $9.25 |
| # Analysts | 5 |
| Recommendation | Strong Buy (1.40) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.06 | $-0.07 | $-0.04 | 45.0% | +8.3% | 2↑ 0↓ | $0.0B | 23.2% | 4 |
| Next Q 2026-09-30 |
$-0.05 | $-0.06 | $-0.04 | 47.5% | +7.4% | 2↑ 0↓ | $0.0B | 59.6% | 4 |
| Current FY 2026-12-31 |
$-0.24 | $-0.27 | $-0.20 | 45.0% | -2.9% | 0↑ 1↓ | $0.0B | 56.7% | 3 |
| Next FY 2027-12-31 |
$-0.17 | $-0.19 | $-0.15 | 28.2% | +5.6% | 2↑ 1↓ | $0.0B | 172.7% | 4 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.055 | |
| 7d ago | $-0.058 | +0.003 |
| 30d ago | $-0.060 | +0.005 |
| 60d ago | $-0.063 | +0.008 |
| 90d ago | $-0.075 | +0.020 |
4 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jun 8, 2026 | Ascendiant Capital | MAINTAIN | Buy | Buy |
| May 15, 2026 | Maxim Group | MAINTAIN | Buy | Buy |
| May 15, 2026 | BTIG | REITERATE | Buy | Buy |
| Apr 9, 2026 | Ascendiant Capital | MAINTAIN | Buy | Buy |
| Mar 30, 2026 | BTIG | REITERATE | Buy | Buy |
| Mar 26, 2026 | Needham | REITERATE | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 3 | 7 | 1 | 0 | 0 | 91% | |
| May 1, 2026 | 3 | 7 | 1 | 0 | 0 | 91% | |
| Apr 1, 2026 | 3 | 7 | 1 | 0 | 0 | 91% | |
| Mar 1, 2026 | 3 | 8 | 1 | 0 | 0 | 92% | |
| Feb 1, 2026 | 3 | 8 | 1 | 0 | 0 | 92% | |
| Jan 1, 2026 | 3 | 8 | 1 | 0 | 0 | 92% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Jun 9, 2026
short_volume
Short Volume: LUCD — 59.8% short (0.3M / 0.5M)
Short: 321,716 | Exempt: 222 | TRF Vol: 538,080 | Short Ratio: 59.8% | Off-exchange volume (dark pool + OTC)
Jun 5, 2026
short_volume
Short Volume: LUCD — 72.2% short (0.4M / 0.6M)
Short: 398,588 | Exempt: 1,786 | TRF Vol: 552,100 | Short Ratio: 72.2% | Off-exchange volume (dark pool + OTC)
May 20, 2026
short_volume
Short Volume: LUCD — 59.3% short (0.5M / 0.9M)
Short: 544,949 | Exempt: 1,115 | TRF Vol: 918,772 | Short Ratio: 59.3% | Off-exchange volume (dark pool + OTC)
May 18, 2026
short_volume
Short Volume: LUCD — 69.3% short (0.4M / 0.6M)
Short: 423,710 | Exempt: 0 | TRF Vol: 611,213 | Short Ratio: 69.3% | Off-exchange volume (dark pool + OTC)
May 15, 2026
short_volume
Short Volume: LUCD — 85.3% short (0.6M / 0.7M)
Short: 609,089 | Exempt: 51 | TRF Vol: 714,428 | Short Ratio: 85.3% | Off-exchange volume (dark pool + OTC)
May 14, 2026
earnings_calendar
LUCD Q1 2026 Earnings Before Market Open — 2026-05-14
May 14, 2026
short_volume
Short Volume: LUCD — 72.1% short (0.7M / 1.0M)
Short: 728,271 | Exempt: 1,073 | TRF Vol: 1,010,002 | Short Ratio: 72.1% | Off-exchange volume (dark pool + OTC)
May 7, 2026
short_volume
Short Volume: LUCD — 58.6% short (0.3M / 0.5M)
Short: 297,958 | Exempt: 923 | TRF Vol: 508,235 | Short Ratio: 58.6% | Off-exchange volume (dark pool + OTC)
Apr 24, 2026
short_volume
Short Volume: LUCD — 59.2% short (0.3M / 0.6M)
Short: 342,622 | Exempt: 26,489 | TRF Vol: 578,317 | Short Ratio: 59.2% | Off-exchange volume (dark pool + OTC)
Apr 14, 2026
short_volume
Short Volume: LUCD — 60.5% short (0.5M / 0.8M)
Short: 507,091 | Exempt: 5,649 | TRF Vol: 838,505 | Short Ratio: 60.5% | Off-exchange volume (dark pool + OTC)
Mar 23, 2026
earnings_calendar
LUCD Q4 2025 Earnings After Market Close — 2026-03-23